Stage II Breast Cancer Recruiting Phase 3 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs